CNBC November 19, 2024
Annika Kim Constantino

Key Points

– President-elect Donald Trump has tapped Robert F. Kennedy Jr., a notorious vaccine skeptic, to lead the Department of Health and Human Services.

– That selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries cautious of potential changes to come.

– But there will be limits to Kennedy’s power since some of his proposals may not easily pass through Congress.

President-elect Donald Trump has tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services – a selection that is raising fears in the public health community and leaving the biotech and pharmaceutical industries bracing for disruptions to drug development.

Trump’s announcement on Thursday gives Kennedy,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, HHS
HHS facing challenges as lead agency for healthcare cybersecurity: GAO
RFK Jr. Promises To ‘Get America Healthy Again’ — and Maybe It’s Possible
'I think there's been an over reaction': UHS CEO on HHS appointment
DEA, HHS issue another extension for telehealth controlled substance prescribing
Telehealth prescribing of controlled drugs extended through 2025

Share This Article